Related Experiment Video
Updated: Jun 3, 2026

Isolation and Analysis of Hematopoietic Stem Cells from the Placenta
Published on: June 24, 2008
Placenta perfusion has hematopoietic and mesenchymal progenitor stem cell potential
Nikos Tsagias1, Iro Koliakos, Maria Lappa
13rd University Obstetrics and Gynaecology Clinic, Ippokration General Hospital, Medical School, Aristotle University Thessaloniki, Thessaloniki, Greece.
Background:
Placenta is a valuable source of stem cells for cell therapy and future application in the field of regenerative medicine. This is due to the plasticity and the immunomodulatory effects of the stem cells that it contains. In this study we present a totally closed method for hematopoietic and nonhematopoietic stem cell isolation from human term placenta.
Study Design And Methods:
Sixty-eight placenta units were collected and manipulated for the residual fetal blood drainage. After delivery, placenta flushing with citrate-phosphate-dextrose-adenine was evaluated.
Results:
Placenta flushing using a totally closed system led to a significant amount of hematopoietic progenitor cells and multipotent mesenchymal stem cells (MSCs) without additional microbial risk, free of maternal cell contamination.
Conclusion:
Traditionally discarded after childbirth, the term placenta now appears to be an easily accessible and abundant source of diverse origin stem cells suitable for banking strategies and for future clinical applications, including adult therapy.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Hematopoiesis
Production of Formed Elements
Most HSCs commit to...
Mesenchymal Stem Cells
Source And Potency Of Stem Cells

